Resmed Inc. buy Mizuho
Start price
27.03.24
/
50%
€181.40
Target price
27.03.25
€198.64
Performance (%)
13.45%
End price
28.03.25
€205.80
Summary
This prediction ended on 28.03.25 with a price of €205.80. The prediction had a final performance of 13.45%. Dividends of €1.93 are taken into consideration when calculating the performance. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 2.165% | 2.165% | -20.241% |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % |
Comments by Mizuho for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $215.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten